This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999:236:237-54.

doi: 10.1007/978-3-642-59951-4_12.

Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm

K Killeen¹, D Spriggs, J Mekalanos

Affiliations

PMID: 9893363
DOI: 10.1007/978-3-642-59951-4_12

Review

Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm

K Killeen et al. Curr Top Microbiol Immunol. 1999.

. 1999:236:237-54.

doi: 10.1007/978-3-642-59951-4_12.

Authors

K Killeen¹, D Spriggs, J Mekalanos

Affiliation

¹ Virus Research Institute, Cambridge, USA.

PMID: 9893363
DOI: 10.1007/978-3-642-59951-4_12

No abstract available

PubMed Disclaimer

Similar articles

The history of live bacterial vaccines.
Lindberg AA. Lindberg AA. Dev Biol Stand. 1995;84:211-9. Dev Biol Stand. 1995. PMID: 7796956
Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae.
Ryan ET, Crean TI, Kochi SK, John M, Luciano AA, Killeen KP, Klose KE, Calderwood SB. Ryan ET, et al. Infect Immun. 2000 Jan;68(1):221-6. doi: 10.1128/IAI.68.1.221-226.2000. Infect Immun. 2000. PMID: 10603391 Free PMC article.
Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.
Butterton JR, Boyko SA, Calderwood SB. Butterton JR, et al. Vaccine. 1993 Oct;11(13):1327-35. doi: 10.1016/0264-410x(93)90103-5. Vaccine. 1993. PMID: 8296486
Experience with registered mucosal vaccines.
Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret JF. Dietrich G, et al. Vaccine. 2003 Jan 30;21(7-8):678-83. doi: 10.1016/s0264-410x(02)00579-0. Vaccine. 2003. PMID: 12531339 Review.
Attenuated salmonella and Shigella as carriers for DNA vaccines.
Xu F, Ulmer JB. Xu F, et al. J Drug Target. 2003;11(8-10):481-8. doi: 10.1080/10611860410001670053. J Drug Target. 2003. PMID: 15203916 Review.

See all similar articles

Cited by

An unnatural amino acid dependent, conditional Pseudomonas vaccine prevents bacterial infection.
Pigula M, Lai YC, Koh M, Diercks CS, Rogers TF, Dik DA, Schultz PG. Pigula M, et al. Nat Commun. 2024 Aug 8;15(1):6766. doi: 10.1038/s41467-024-50843-7. Nat Commun. 2024. PMID: 39117651 Free PMC article.
[Use of lactic acid bacteria as mucosal vaccines].
Bermúdez-Humarán LG, Langella P. Bermúdez-Humarán LG, et al. Rev Francoph Lab. 2009 Dec;2009(417):79-89. doi: 10.1016/S1773-035X(09)70312-0. Epub 2009 Dec 11. Rev Francoph Lab. 2009. PMID: 32518601 Free PMC article. French.
Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.
Vemulapalli R, He Y, Boyle SM, Sriranganathan N, Schurig GG. Vemulapalli R, et al. Infect Immun. 2000 Jun;68(6):3290-6. doi: 10.1128/IAI.68.6.3290-3296.2000. Infect Immun. 2000. PMID: 10816476 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database